Suzuken Co., Ltd. (TYO: 9987)

Market Cap	366.12B
Revenue (ttm)	2.39T
Net Income (ttm)	33.41B
Shares Out	77.67M
EPS (ttm)	425.43
PE Ratio	11.08
Forward PE	12.92
Dividend	100.00 (2.13%)
Ex-Dividend Date	Mar 28, 2025

Volume	18,500
Average Volume	226,150
Open	4,730.00
Previous Close	4,714.00
Day's Range	4,717.00 - 4,754.00
52-Week Range	4,358.00 - 5,549.00
Beta	0.16
RSI	49.82
Earnings Date	Feb 12, 2025

About Suzuken

Suzuken Co., Ltd., together with its subsidiaries, primarily engages in the distribution of pharmaceuticals in Japan and internationally. The company operates in four segments: Pharmaceutical Distribution, Pharmaceutical Manufacturing, Pharmacy, and Healthcare-Related Services. The Pharmaceutical Distribution Business segment is involved in the purchase and sale of ethical drugs, pharmaceuticals, diagnostic reagents, and medical equipment and supplies to medical institutions and insurance pharmacies. The Pharmaceutical Manufacturing Business se...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1932
• Employees: 13,086
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 9987

Financial Performance

In 2023, Suzuken's revenue was 2.39 trillion, an increase of 3.10% compared to the previous year's 2.31 trillion. Earnings were 29.02 billion, an increase of 42.62%.